---
document_datetime: 2023-09-21 21:28:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/biktarvy-epar-all-authorised-presentations_en.pdf
document_name: biktarvy-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.156411
conversion_datetime: 2025-12-17 08:48:48.855821
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength               | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                       |
|------------------|-------------------|------------------------|-----------------------|---------------------------|-----------------------|---------------------------------|
| EU/1/18/1289/001 | Biktarvy          | 50 mg / 200 mg / 25 mg | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 30 tablets                      |
| EU/1/18/1289/002 | Biktarvy          | 50 mg / 200 mg / 25 mg | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 90 (3 x 30) tablets             |
| EU/1/18/1289/003 | Biktarvy          | 50 mg / 200 mg / 25 mg | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE)   | 30 tablets                      |
| EU/1/18/1289/004 | Biktarvy          | 50 mg / 200 mg / 25 mg | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE)   | 90 (3 x 30) tablets (multipack) |
| EU/1/18/1289/005 | Biktarvy          | 30 mg / 120 mg / 15 mg | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 30 tablets                      |
| EU/1/18/1289/006 | Biktarvy          | 30 mg / 120 mg / 15 mg | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 90 (3 x 30) tablets             |